The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
According to Amgen's latest financial reports the company has HK$93.08 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | HK$92.95 B | 8.75% |
2023-12-31 | HK$85.47 B | 17.57% |
2022-12-31 | HK$72.70 B | 16.01% |
2021-12-31 | HK$62.66 B | -24.07% |
2020-12-31 | HK$82.53 B | 18.93% |
2019-12-31 | HK$69.39 B | -69.76% |
2018-12-31 | HK$229.47 B | -29.53% |
2017-12-31 | HK$325.62 B | 10.26% |
2016-12-31 | HK$295.33 B | 21.42% |
2015-12-31 | HK$243.23 B | 16.03% |
2014-12-31 | HK$209.62 B | 39.34% |
2013-12-31 | HK$150.44 B | -19.33% |
2012-12-31 | HK$186.50 B | 16.33% |
2011-12-31 | HK$160.31 B | 18.24% |
2010-12-31 | HK$135.58 B | 30.09% |
2009-12-31 | HK$104.22 B | 41.2% |
2008-12-31 | HK$73.81 B | 32.39% |
2007-12-31 | HK$55.75 B | 14.21% |
2006-12-31 | HK$48.81 B | 19.82% |
2005-12-31 | HK$40.74 B | -9.73% |
2004-12-31 | HK$45.13 B | 13.66% |
2003-12-31 | HK$39.70 B | 9.18% |
2002-12-31 | HK$36.37 B | 75.21% |
2001-12-31 | HK$20.75 B | 31.24% |
2000-12-31 | HK$15.81 B | 52.74% |
1999-12-31 | HK$10.35 B | 564.67% |
1998-12-31 | HK$1.55 B | -15.91% |
1997-12-31 | HK$1.85 B | 41.5% |
1996-12-31 | HK$1.30 B |